Resistance to antimicrobial drugs (Z16)
ICD-10 code range Z16 is specifically used to identify different types of resistance to antimicrobial drugs. These codes help document cases where bacteria or other microbes are resistant to antibiotics, antifungals, antivirals, or antiparasitic agents, which is critical for effective treatment planning and infection control.
This code chapter covers resistance to diverse drugs, including beta lactam antibiotics (Z16.1) like penicillins (Z16.11) and extended spectrum beta lactamase producing bacteria (Z16.12), which are often called "Beta lactam resistant bacterial infections." It also includes resistance to powerful antibiotics such as carbapenems (Z16.13, Z16.19) and vancomycin (Z16.21) used for severe infections, plus resistance to quinolones and fluoroquinolones (Z16.23) common in treating tuberculosis and other bacterial infections. Codes like Z16.24 and Z16.35 cover cases of multidrug resistance, highlighting infections by multi drug resistant bacteria or Acinetobacter. Resistance to antifungal (Z16.32) or antiviral drugs (Z16.33) is similarly addressed. Antimycobacterial drug resistance is detailed with codes for single (Z16.341) and multiple drug resistance (Z16.342), important for documenting antibiotic resistant tuberculosis. This granularity supports accurate clinical documentation of drug resistance patterns crucial for patient care and public health.
Factors influencing health status and contact with health services (Z00–Z99)
Resistance to antimicrobial drugs (Z16)
Z16 Resistance to antimicrobial drugs
Z16.1 Resistance to beta lactam antibiotics
- Z16.10 Resistance to unspecified beta lactam antibiotics
- Z16.11 Resistance to penicillins
- Z16.12 Extended spectrum beta lactamase (ESBL) resistance
- Z16.13 Resistance to carbapenem
- Z16.19 Resistance to other specified beta lactam antibiotics
Z16.2 Resistance to other antibiotics
- Z16.20 Resistance to unspecified antibiotic
- Z16.21 Resistance to vancomycin
- Z16.22 Resistance to vancomycin related antibiotics
- Z16.23 Resistance to quinolones and fluoroquinolones
- Z16.24 Resistance to multiple antibiotics
- Z16.29 Resistance to other single specified antibiotic
Z16.3 Resistance to other antimicrobial drugs
- Z16.30 Resistance to unspecified antimicrobial drugs
- Z16.31 Resistance to antiparasitic drug(s)
- Z16.32 Resistance to antifungal drug(s)
- Z16.33 Resistance to antiviral drug(s)
Z16.34 Resistance to antimycobacterial drug(s)
- Z16.341 Resistance to single antimycobacterial drug
- Z16.342 Resistance to multiple antimycobacterial drugs
- Z16.35 Resistance to multiple antimicrobial drugs
- Z16.39 Resistance to other specified antimicrobial drug
Resistance to antimicrobial drugs (Z16)
Instructional Notations
Code First
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists, there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.
- the infection
Type 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
- Methicillin resistant Staphylococcus aureus infection A49.02
- Methicillin resistant Staphylococcus aureus pneumonia J15.212
- Sepsis due to Methicillin resistant Staphylococcus aureus A41.02
- The codes in this category are provided for use as additional codes to identify the resistance and non-responsiveness of a condition to antimicrobial drugs.